← Back to Search

Behavioral Intervention

Perturbation Training for Alzheimer's Disease (STAD Trial)

Verified Trial
N/A
Recruiting
Led By Feng Yang, PhD
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants can read and understand English
Participants must be able to walk independently at least 25 feet
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

STAD Trial Summary

This trialwill look at how people w/ Alzheimer's learn to reduce falls through special training.

Who is the study for?
This trial is for English-speaking individuals aged 65 or older with probable Alzheimer's Disease who can walk and stand independently. They must have certain scores on cognitive tests indicating moderate impairment but cannot have had perturbation training before, osteoporosis, other major psychiatric or neurological conditions, injuries, or uncontrolled blood pressure issues.Check my eligibility
What is being tested?
The study is testing the effectiveness of perturbation training in teaching people with Alzheimer's Disease how to resist falls better. Perturbation training involves controlled exposure to disturbances that challenge balance.See study design
What are the potential side effects?
While specific side effects are not listed for this type of physical training, participants may experience fatigue, muscle soreness, or discomfort from the exercises involved in perturbation training.

STAD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk by myself for at least 25 feet.
Select...
I can stand on my own for at least 30 seconds.

STAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lab-induced faller rate
Secondary outcome measures
Dynamic stability
Number of prospective fall incident
Other outcome measures
Berg Balance Scale
Mobility
Muscle strength
+2 more

STAD Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Training groupExperimental Treatment1 Intervention
This arm will receive a single-session perturbation training treatment on a treadmill under the protection of a safety harness.
Group II: Control groupPlacebo Group1 Intervention
This arm will not receive perturbation training but will go through harnessed walking on the same treadmill for the same time as the other group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Perturbation training
2021
N/A
~140

Find a Location

Who is running the clinical trial?

Georgia State UniversityLead Sponsor
57 Previous Clinical Trials
25,399 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,846 Total Patients Enrolled
Alzheimer's AssociationOTHER
90 Previous Clinical Trials
40,743 Total Patients Enrolled

Media Library

Perturbation training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05205980 — N/A
Alzheimer's Disease Research Study Groups: Control group, Training group
Alzheimer's Disease Clinical Trial 2023: Perturbation training Highlights & Side Effects. Trial Name: NCT05205980 — N/A
Perturbation training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05205980 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the age limit for participants in this clinical trial?

"As noted, the age range for this study is 65 to 90 years old."

Answered by AI

Who else is applying?

What site did they apply to?
Reminiscent
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Average response time
  • < 1 Day
Typically responds via
Phone Call
Most responsive sites:
  1. Reminiscent: < 24 hours
Recent research and studies
clinicaltrials.govStudy
Perturbation Training Reduces Falls in People With AD
Feng Yang, PhD 2023. "Perturbation Training Reduces Falls in People With AD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05205980.
~4 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top